乐普药业科技有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
NMPA:7
Drug Approvals
Lenvatinib Mesilate Capsules
- Product Name
- 甲磺酸仑伐替尼胶囊
- Approval Number
- 国药准字H20247188
- Approval Date
- Aug 9, 2024
NMPA
Lenvatinib Mesilate Capsules
- Product Name
- 甲磺酸仑伐替尼胶囊
- Approval Number
- 国药准字H20233297
- Approval Date
- Mar 21, 2023
NMPA
Losartan Potassium and Hydrochlorothiazide Tablets
- Product Name
- 氯沙坦钾氢氯噻嗪片
- Approval Number
- 国药准字H20123367
- Approval Date
- Jul 18, 2022
NMPA
Losartan Potassium and Hydrochlorothiazide Tablets
- Product Name
- 氯沙坦钾氢氯噻嗪片
- Approval Number
- 国药准字H20217082
- Approval Date
- Jul 18, 2022
NMPA
Clinical Trials
No trials found
News
No news found